During the third quarter of 2022, the BeautyMatter Deal Index tracked 67 deals, a 27% decline from Q2 2022 and a similar decline year over year. In the context of the unprecedented amount of deal activity we saw in 2021 and the early part of 2022, this decline indicates a marked shift in investor and strategic appetite for beauty and wellness deals. Seen against the context of historic, pre-pandemic trends, however, Q3 2022 deal activity was still above average and shows that investors, while more cautious, remain enthusiastic about the prospects of earning meaningful returns from beauty and wellness dealmaking.
Beauty Deals: Investment + M&A Transactions Q3 2022:
